indolepropionic acid has been researched along with Multiple Sclerosis in 1 studies
indolepropionic acid: structure in third source
3-(1H-indol-3-yl)propanoic acid : An indol-3-yl carboxylic acid that is propionic acid substituted by a 1H-indol-3-yl group at position 3.
Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rothhammer, V | 1 |
| Mascanfroni, ID | 1 |
| Bunse, L | 1 |
| Takenaka, MC | 1 |
| Kenison, JE | 1 |
| Mayo, L | 1 |
| Chao, CC | 1 |
| Patel, B | 1 |
| Yan, R | 1 |
| Blain, M | 1 |
| Alvarez, JI | 1 |
| Kébir, H | 1 |
| Anandasabapathy, N | 1 |
| Izquierdo, G | 1 |
| Jung, S | 1 |
| Obholzer, N | 1 |
| Pochet, N | 1 |
| Clish, CB | 1 |
| Prinz, M | 1 |
| Prat, A | 1 |
| Antel, J | 1 |
| Quintana, FJ | 1 |
1 other study available for indolepropionic acid and Multiple Sclerosis
| Article | Year |
|---|---|
Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.
Topics: Animals; Astrocytes; Case-Control Studies; Cell Proliferation; Central Nervous System; Chemokine CCL | 2016 |